Novartis Aktie
100,20
EUR
+1,14
EUR
+1,15
%
93,50
CHF
+1,35
CHF
+1,47
%
Werbung
Novartis Aktie Analyse
21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.06.17 | Novartis Hold | Deutsche Bank AG | |
21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
21.06.17 | Novartis buy | HSBC | |
16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
06.06.17 | Novartis Underweight | Morgan Stanley | |
Werbung
|
|||
02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Underweight | Barclays Capital | |
02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
01.06.17 | Novartis buy | Jefferies & Company Inc. | |
24.05.17 | Novartis Neutral | UBS AG | |
19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
12.05.17 | Novartis buy | Jefferies & Company Inc. | |
12.05.17 | Novartis Underweight | Morgan Stanley | |
26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
26.04.17 | Novartis Underweight | Morgan Stanley | |
26.04.17 | Novartis Hold | Deutsche Bank AG | |
25.04.17 | Novartis Hold | S&P Capital IQ | |
21.04.17 | Novartis Neutral | UBS AG | |
19.04.17 | Novartis Underweight | Morgan Stanley | |
18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
11.04.17 | Novartis Hold | Deutsche Bank AG | |
06.04.17 | Novartis Neutral | UBS AG | |
23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.03.17 | Novartis buy | Kepler Cheuvreux | |
23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.03.17 | Novartis Hold | Deutsche Bank AG | |
15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.03.17 | Novartis Neutral | UBS AG | |
10.03.17 | Novartis Hold | Deutsche Bank AG | |
09.03.17 | Novartis buy | Jefferies & Company Inc. | |
08.03.17 | Novartis Underweight | Barclays Capital | |
08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
07.03.17 | Novartis Underperform | BNP PARIBAS | |
17.02.17 | Novartis buy | Jefferies & Company Inc. | |
06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
30.01.17 | Novartis Neutral | UBS AG | |
30.01.17 | Novartis buy | HSBC | |
26.01.17 | Novartis Underweight | Morgan Stanley | |
26.01.17 | Novartis Hold | Deutsche Bank AG | |
25.01.17 | Novartis Hold | S&P Capital IQ | |
25.01.17 | Novartis Outperform | Bernstein Research |
Werbung
Werbung